Showing results (141-150 of 529) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|July 16, 2016
Periprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventionsP Widimský, V Kočka, F Roháč, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 31, 2025
Long-term effectiveness of ACE inhibitors or angiotensin receptor blockers in myocardial infarction with preserved left ventricular ejection fractionAnna B C Humphreys, Bertil Lindahl, Anita Berglund, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 29, 2020
The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin systemAnnette Offringa, Roy Montijn, Sandeep Singh, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 17, 2017
Advocating cardiovascular precision medicine with P2Y12 receptor inhibitorsMax-Paul Winter, Erik L Grove, Raffaele De Caterina, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 30, 2016
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulantsSigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 18, 2021
Epinephrine administration for adult out-of-hospital cardiac arrest patients with refractory shockable rhythm: time-dependent propensity score-sequential matching analysis from a nationwide population-based registryTasuku Matsuyama, Sho Komukai, Junichi Izawa, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 27, 2021
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma Forton Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 13, 2019
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trialsHeinz Drexel, Giuseppe M C Rosano, Basil S Lewis, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 29, 2022
Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trialAtsushi Tanaka, Masataka Sata, Yosuke Okada, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 24, 2025
Lipid-lowering and antihypertensive drugs on aortic disease risk: insights from Mendelian randomization analysis and real-world pharmacovigilance dataHan Nie, Wenpeng Zhao, Qingqing Wang, et al.
Pageof 53